Q3 FY25 Financial Highlights (INR Crore)
| Particulars | Q3 FY25 (31.12.2024) | Q2 FY25 (30.09.2024) | Q3 FY24 (31.12.2023) | 9M FY25 (31.12.2024) | 9M FY24 (31.12.2023) | FY24 (31.03.2024) |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹324.93 | ₹349.82 | ₹306.46 | ₹1,022.61 | ₹929.97 | ₹1,244.70 |
| Total Income | ₹330.06 | ₹355.87 | ₹310.73 | ₹1,038.91 | ₹941.97 | ₹1,261.59 |
| Total Expenses | ₹285.53 | ₹298.94 | ₹270.06 | ₹877.86 | ₹817.42 | ₹1,095.48 |
| Profit Before Tax (PBT) | ₹44.53 | ₹56.93 | ₹40.67 | ₹161.05 | ₹124.55 | ₹166.11 |
| Profit After Tax (PAT) | ₹32.81 | ₹42.40 | ₹29.44 | ₹119.98 | ₹92.79 | ₹123.96 |
| Total Comprehensive Income | ₹32.70 | ₹41.20 | ₹30.89 | ₹120.65 | ₹93.68 | ₹125.81 |
| Earnings Per Share (EPS) (₹) | ₹3.58 | ₹4.63 | ₹3.21 | ₹13.09 | ₹10.12 | ₹13.52 |
Performance Highlights
- Revenue Growth: IMCL posted ₹324.93 crore in Q3 FY25, reflecting a 6% year-on-year (YoY) increase from ₹306.46 crore in Q3 FY24. The nine-month revenue rose to ₹1,022.61 crore, compared to ₹929.97 crore in the same period last year.
- Profitability: The Profit After Tax (PAT) for Q3 FY25 stood at ₹32.81 crore, up from ₹29.44 crore in Q3 FY24, showcasing a strong bottom-line performance.
- Earnings Per Share (EPS): The EPS for Q3 FY25 was ₹3.58, up from ₹3.21 in Q3 FY24, reflecting improved earnings per equity share.
- Expense Analysis:
- Employee benefits expenses rose to ₹72.18 crore from ₹66.48 crore in Q3 FY24.
- Professional charges to doctors increased to ₹86.04 crore, up from ₹77.05 crore in the same period last year.
- Depreciation & amortization expenses stood at ₹11.21 crore, reflecting ongoing investments in infrastructure and technology.
Business Outlook
IMCL, operating in the single-segment healthcare industry, remains focused on expanding its medical services, optimizing operational efficiency, and strengthening financial performance. With a growing revenue base and improved profitability, the company aims to maintain its market leadership in the healthcare sector.
Last edited: